ArticleFacts, views & vision in ObGyn2025
Conservative management of caesarean scar pregnancy: tissue removal device hysteroscopic treatment after uterine artery embolisation.
Article in Facts, views & vision in ObGyn, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Session No-Touch Hysteroscopic Mechanical Resection for Cesarean Scar Pregnancy: A Novel Primary Treatment Approach.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Caesarean scar pregnancy (CSP) is an uncommon complication in women with prior caesarean deliveries. Treatment options include both medical and surgical approaches, but there is no consensus on definitive management. Objectives: We propose a step-by-step video demonstration of a conservative approach for CSP, using hysteroscopic treatment with tissue removal device (TRD) after uterine artery embolisation (UAE). Participant: A 34-year-old woman with two previous caesarean deliveries was diagnosed with a CSP involving an 8-week embryo implanted in the isthmocele. Initial management consisted of UAE performed at another hospital. The patient was then referred to the Digital Hysteroscopic Clinic, CLASS Hysteroscopy of Policlinico Gemelli in Rome, for hysteroscopic removal of residual trophoblastic tissue. Intervention: Safety and effectiveness of a novel conservative CSP management, involving TRD following UAE. Preoperative assessment, combining transvaginal ultrasound and diagnostic hysteroscopy, revealed trophoblastic remnants inside the uterine niche with an extremely thin myometrial margin. The procedure was performed under general anaesthesia, according to an ambulatory model of care. A TRD with a soft tissue blade was used for the complete removal of the lesion. Conclusions: This video article suggests that TRD hysteroscopic treatment after UAE is a safe and effective approach for CSP. This conservative management minimises the risk of complications such as bleeding and uterine perforation. Additionally, the TRD avoids the use of electrosurgery, potentially reducing the incidence of subsequent intrauterine adhesions. Further studies are needed to confirm these results in the long term. What is New?: This is the first reported case of conservative CSP management combining UAE with hysteroscopic resection using a TRD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.